An interventional study of Culturally Based Diabetes Self-Management Education (DSME) and General Diabetes Education and Counselling in Type 2 Diabetes Mellitus (DM), sponsored by Hasanuddin University. Completed at 1 site in Indonesia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Hasanuddin University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 67 studies in Diabetes Mellitus, Type 2 with a site in Indonesia — 9 open to participants now, 10 under way, 2 of them phase 3. Diabetes Mellitus, Type 2 · Indonesia.
Among the 67 studies in Diabetes Mellitus, Type 2 with a site in Indonesia, this one is the 25th largest by enrollment of the 53 interventional ones that give a count, is one of 8 that started in 2025, is one of 26 with no phase, and was the 67th registered.
10,396 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →9 of the 67 studies in Diabetes Mellitus, Type 2 with a site in Indonesia are open now. Recruiting first, the newest first:
Universitas Sriwijaya · Sites in Indonesia
Ages 30–65
Novo Nordisk A/S · Sites in Indonesia, Malaysia, Philippines and 1 more country
Ages 40–70
Indonesia University · Sites in Indonesia
Ages 35–59
Boryung Pharmaceutical Co., Ltd · Sites in Indonesia, Korea, Republic of
Ages 19+
Indonesia University · Sites in Indonesia
Ages 8–40 · Healthy volunteers
A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →
Of the 880 Diabetes Mellitus, Type 2 studies recruiting now, 374 (43%) set no upper age limit and 381 (43%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
67 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 8 · Phase 3 10 · Phase 4 8
First in 2003; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 96 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 90 across the 53 interventional studies, 1,750 across the 14 observational. Of the 48 that completed or were terminated, 2 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
28 of 67 have an industry lead sponsor. The 10 most frequent:
Hasanuddin University is the lead sponsor of 71 studies on the registry; 6 are open to participants now.
Hasanuddin University has 2 studies filed under Diabetes Mellitus, Type 2 — fewer than ten, so there is no comparison to draw.
4 of the studies in Diabetes Mellitus, Type 2 with a site in Indonesia that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06220773Phase 3Boryung Pharmaceutical Co., LtdA Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy | 2026-12 |
| NCT07064486Phase 3BrightGene Bio-Medical Technology Co., Ltd.A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia | 2027-04-30 |
| NCT07928661Universitas SriwijayaEffect of Proliverenol on Liver Fat and Insulin Resistance in Type 2 Diabetes | 2026-12 |
| NCT07532863Novo Nordisk A/SA Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants | 2027-03-27 |
Add all 4 to your calendar (.ics) → With an account.
Among the 67 studies in Diabetes Mellitus, Type 2 with a site in Indonesia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Type 2 diabetes is a long-term condition that requires patients to manage their diet, physical activity, medication, and blood glucose levels regularly. Diabetes self-management education can help patients improve their knowledge and daily self-care practices. However, educational programs may be more effective when they consider patients' local culture, language, food habits, and family values.
This study evaluated the effectiveness of a culturally based Diabetes Self-Management Education (DSME) model among adults with type 2 diabetes in Bone Regency, South Sulawesi, Indonesia. The study involved participants from Puskesmas Cina and used a quasi-experimental design with intervention and control groups.
Participants in the intervention group received general counselling supported by a culturally based DSME module developed for the Bugis community. The module covered basic diabetes knowledge, nutrition using locally available foods, physical activity, blood glucose monitoring, foot care, stress management, and family support. The education was delivered in four group sessions, once a week for four consecutive weeks. Participants in the control group received general diabetes counselling without the culturally based module.
The study assessed quality of life, diabetes knowledge, self-management practices, and blood glucose levels. Fasting blood glucose and two-hour post-meal blood glucose were monitored over 12 weeks. Quality of life, knowledge, and self-management were assessed before the intervention and at three months.
The purpose of this study was to determine whether culturally based diabetes education could improve quality of life, diabetes self-management, and blood glucose control compared with general diabetes counselling.
The culturally based Diabetes Self-Management Education (DSME) model was developed to address the influence of local culture, language, food practices, family relationships, and community values on diabetes self-management among people with type 2 diabetes in the Bugis community of South Sulawesi, Indonesia.
The intervention was developed through a staged research process informed by the Medical Research Council framework for complex interventions. The first stage involved a qualitative study exploring the experiences, needs, barriers, and cultural context of Bugis people living with type 2 diabetes. The second stage involved a Delphi study to obtain expert consensus on the educational content, delivery strategies, cultural appropriateness, and feasibility of the DSME model. Following expert consensus, the educational module was reviewed by a media expert and pilot-tested among nine people with type 2 diabetes before implementation.
The culturally based DSME model incorporated Bugis cultural values, particularly siatutui (caring for and looking after one another) and sipakainge (reminding one another). These values were integrated into diabetes education to encourage mutual support, family involvement, and continued self-management practices.
The intervention consisted of four structured group education sessions delivered once weekly over four consecutive weeks. Each session lasted approximately 45 to 90 minutes and was conducted using a combination of Indonesian and Bugis languages. Participants received a printed educational module at the beginning of the first session and were allowed to take it home for continued reference and daily self-management practice.
The educational content covered four main areas:
The cultural adaptation focused not only on the use of local language but also on incorporating familiar food examples, local expressions, family values, and practical strategies relevant to everyday life in the Bugis community.
Participants in the control group received general diabetes education without the culturally based DSME module. The control education addressed the basic concepts and disease processes of diabetes, glycemic control targets, nutritional management, physical activity, medication adherence, and self-monitoring of blood glucose.
Implementation fidelity was monitored using implementation checklists, supervision, observation, and documentation to assess whether the planned educational content and delivery schedule were followed.
The study evaluated the intervention in a primary healthcare setting to determine whether integrating cultural values and locally relevant educational content into diabetes self-management education could improve health-related quality of life, diabetes knowledge, self-management practices, and glycemic control among adults with type 2 diabetes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received general diabetes counselling supplemented with a culturally based Diabetes Self-Management Education (DSME) module developed for the Bugis community. The intervention consisted of four group education sessions delivered once weekly over four consecutive weeks, with each session lasting approximately 45-90 minutes. The sessions used Indonesian and Bugis languages and covered basic diabetes knowledge, diet and nutrition using locally available foods, physical activity, blood glucose monitoring, foot care, stress management, and family support. The module incorporated Bugis cultural values, including siatutui and sipakainge.
Behavioral: Culturally Based Diabetes Self-Management Education (DSME) · Behavioral: General Diabetes Education and Counselling
Participants received general diabetes education and counselling without the culturally based DSME module. The education covered the basic concepts and disease processes of diabetes, including its definition, aetiology, and clinical manifestations; glycaemic control targets; nutritional management; physical activity; medication adherence; and self-monitoring of blood glucose.
Behavioral: Culturally Based Diabetes Self-Management Education (DSME) · Behavioral: General Diabetes Education and Counselling
A culturally based Diabetes Self-Management Education (DSME) module developed for the Bugis community. The intervention was delivered through four group education sessions, conducted once weekly over four consecutive weeks, with each session lasting approximately 45-90 minutes. The sessions covered basic diabetes knowledge; diet and nutrition using locally available foods; physical activity and blood glucose monitoring; and foot care, stress management, and family support. The educational content incorporated Indonesian and Bugis languages and local cultural values, particularly siatutui (looking after one another) and sipakainge (reminding one another).
General diabetes education and counselling provided to participants in the control group without the culturally based DSME module. The education covered the basic concepts and disease processes of diabetes, including its definition, aetiology, and clinical manifestations; glycaemic control targets; nutritional management; physical activity; medication adherence; and self-monitoring of blood glucose.
Quality of Life Measured by WHOQOL-BREF
Quality of life was assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF), which evaluates four domains: physical health, psychological health, social relationships, and environment. The assessment was conducted to evaluate changes in quality of life following the intervention.
Time frame: At baseline (before the intervention) and 3 months after the intervention.
Diabetes Knowledge Measured by the Diabetes Knowledge Questionnaire (DKQ)
Diabetes knowledge was assessed using the Diabetes Knowledge Questionnaire (DKQ) to evaluate participants' understanding of type 2 diabetes mellitus and its management. Higher scores indicate better diabetes knowledge.
Time frame: At baseline (before the intervention) and 3 months after the intervention.
Diabetes Self-Management
Diabetes self-management was assessed using a self-management questionnaire, referred to as SMDM in the study results, to evaluate participants' diabetes self-management practices. Higher scores indicate better self-management.
Time frame: At baseline (before the intervention) and 3 months after the intervention.
Fasting Blood Glucose (FBG)
Fasting blood glucose was measured using capillary blood samples obtained by finger prick, glucose test strips, and an Accu-Pro glucometer. Lower FBG values indicate improved glycaemic control.
Time frame: At baseline, at 1 month and 3 months after the intervention, and twice weekly for 12 weeks.
2-Hour Postprandial Blood Glucose (2hPPG)
Two-hour postprandial blood glucose was measured using capillary blood samples obtained by finger prick, glucose test strips, and an Accu-Pro glucometer. Lower 2hPPG values indicate improved glycaemic control.
Time frame: At baseline, at 1 month and 3 months after the intervention, and twice weekly for 12 weeks.
Plan to share: No — Individual participant data (IPD) will not be shared with other researchers because of participant confidentiality and data privacy considerations. Study findings will be disseminated through scientific publications and presentations using aggregated data only.
No publications or documents are linked to this record.
Ran from Feb 2025 to primary completion in Aug 2025, 6 months.
Of 2,072 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's 6 months is below that.
Counting every sponsor, half of 2,249 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hasanuddin University